Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 25, 2021

View Archived Issues

Understanding DNA repair mechanisms allows for crisper CRISPR genome editing

Biallelic variants in the KARS1 gene tied to neurodevelopmental disorders and hearing loss

CHD8 haploinsufficiency leads to seizure phenotype

Bayer and collaborators describe new EGFR inhibitors

Monash University divulges antibiotic peptide-drug conjugates

PKMYT1 inhibitors discovered at Repare Therapeutics

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent GLP-1 receptor agonists

Shanghai Synergy Pharmaceutical Sciences, Zhejiang Huahai Pharmaceutical identify kinase inhibitors

Novel mouse model of spontaneously occurring endometriosis created

Fusion Pharmaceuticals evaluates alpha particle-emitting NTSR1 antagonist for colorectal cancer

AAV9-Galns gene therapy corrects mucopolysaccharidosis type IVA pathology in vivo

Novel PSMA-targeting ligand PSMA-TO-1 shows prolonged circulation time and higher tumor uptake

ABHD16A deficiency linked to subtype of complicated hereditary spastic paraplegia

Gene-protein-disease map reveals connections within and between diseases

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...